Skip to main content
. 2015 Oct 4;6(37):39538–39549. doi: 10.18632/oncotarget.5946

Table 2. Differences in odds of individual grade 3/4 AEs between studies with available companion diagnostics and those without companion diagnostics.

AEs, adverse events, CI, confidence interval; OR, odds ratio

Adverse event Companion Diagnostics No Companion Diagnostics P for difference
Number of included studies OR 95% CI Number of included studies OR 95% CI
Anemia 8 0.79 0.62-1.00 12 1.14 0.89-1.46 0.04
Neutropenia 10 0.39 0.33-0.44 10 1.40 1.20-1.63 <0.001
Thrombocytopenia 5 5.18 3.09-8.66 12 1.66 1.23-2.22 <0.001
Diarrhea 14 1.29 1.07-1.55 22 2.43 2.08-2.83 <0.001
Vomiting 9 0.86 0.65-1.14 20 1.44 1.14-1.83 0.005
Stomatitis 7 1.53 0.78-3.02 14 2.59 2.01-3.33 0.16
Cutaneous toxicity 11 1.82 1.45-2.28 18 3.88 3.06-4.94 <0.001
Asthenia/Fatigue 14 0.99 0.79-1.23 24 1.23 1.11-1.37 0.07
Pulmonary/Dyspnea 6 1.15 0.84-1.57 11 0.90 0.74-1.09 0.19
Hypertension 5 5.95 3.03-11.67 14 5.87 4.74-7.26 0.97
Cardiac 4 1.57 1.11-2.23 3 6.88 1.25-37.82 0.10
Neuropathy 3 0.64 0.40-1.01 3 1.60 1.20-2.12 <0.001